Trial intelligence / Profile preview

Kaempferol Gel for Dental Implant Healing

NCT07156799Completed

Sponsor
Al-Azhar University
Start
Jun 2023
Primary completion
Jun 2024
Modality
Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
Countries
1
01

Overview

Randomised trial of kaempferol in tooth loss (2 arms), sponsored by Al-Azhar University. Primary endpoint: Alkaline Phosphatase at 4 weeks. Started Jun 2023; status: completed.

02

Drugs

kaempferol
03

Conditions

tooth loss

Beyond the preview

Go deeper on NCT07156799.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07156799.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call